RSCM
BPMC

Rock Springs Capital Management’s Blueprint Medicines BPMC Stock Holding History

Rock Springs Capital Management’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-57,000
Closed -$6.14M – 110
2024
Q2 		$6.14M Buy
+57,000
New +$5.71M 0.18% 78

Other funds holding BPMC

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Rock Springs Capital Management's BPMC Position: Q3 2025 in Review

Rock Springs Capital Management sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 185,500 shares — an estimated $23.8M sold.

Rock Springs Capital Management first reported a position in BPMC in Q3 2017 and held it in 32 quarters. The position peaked at $266M in Q4 2023. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

  • Rock Springs Capital Management reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
  • Rock Springs Capital Management sold 185,500 Blueprint Medicines shares in Q3 2025, an estimated $23.8M.
  • Rock Springs Capital Management first reported a position in Blueprint Medicines in Q3 2017 and held it in 32 quarters.
  • Rock Springs Capital Management's Blueprint Medicines position peaked at $266M in Q4 2023.
  • 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on Rock Springs Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.